Stay updated on Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.

Latest updates to the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page
- Check4 days agoChange DetectedThe page's revision indicator was updated to v3.5.4, signaling a minor backend/template update that does not alter the displayed study information.SummaryDifference0.1%

- Check11 days agoChange DetectedNew date entries were added to the study record, including recent updates and an estimated completion date of 2026-11-02. Older date entries were removed, indicating a refreshed record timeline.SummaryDifference0.3%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedClinicalTrials.gov’s page release/version tag was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision: v3.5.2 replaces the previous v3.5.0 revision on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision label on the page updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision history shows addition of v3.4.3 and deletion of v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Cisplatin, Radiation & Pembrolizumab Clinical Trial page.